Saudi Food and Drug Authority detects 47 violating facilities

The SFDA confirmed that it had detected violations during its monitoring and inspection rounds in August of this year in all regions of Saudi Arabia

  
A man wearing a protective mask, buys masks from a pharmacy, after the government lifted coronavirus disease (COVID-19) lockdown restrictions, in Riyadh, Saudi Arabia July 5, 2020. Image used for illustrative purpose.

A man wearing a protective mask, buys masks from a pharmacy, after the government lifted coronavirus disease (COVID-19) lockdown restrictions, in Riyadh, Saudi Arabia July 5, 2020. Image used for illustrative purpose.

REUTERS/Ahmed Yosri

RIYADH The Food and Drug Authority (SFDA) announced that it had detected 47 violating facilities and imposed a total fine of SR2,60,83,000.

The SFDA confirmed that it had detected violations during its monitoring and inspection rounds in August of this year in all regions of Saudi Arabia.

They are as follows:

- 20 facilities did not commit to providing pharmaceutical products to the local market, as it imposed a fine of SR773,000.

- 7 facilities did not commit to registering in the monitoring system "Rasd", and were imposed a fine of SR210,000.

- 20 facilities did not commit to reporting directly about the movement of drugs in the electronic tracking system to the competent authorities, and were imposed a fine of SR2,51,00,000.

The SFDA clarified that it obliges pharmaceutical factories and warehouses to have sufficient stock for a period of 6 months of all of their products that have been registered in the authority.

The obligation is mandatory after the new decision at the beginning of this year, which gave the authority the responsibility to set penalties for violations that are monitored in all regions of the Kingdom.

The authority said that consumers could inform the Ministry of Health if they notice that medicines are not available in hospitals or pharmacies.

 

© Copyright 2021 The Saudi Gazette. All Rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More From Commercial